Bonus BioGroup Ltd

Bonus BioGroup Ltd is a biotechnology company based in Israel that specializes in tissue engineering and regenerative medicine. The company was founded in 2008 and is headquartered in Haifa, Israel. The company's market cap as of May 2023 is about $74.5M.

The company's vision is to develop innovative solutions for tissue regeneration and repair, using its proprietary technology of culturing human cells and tissues in bioreactors. The company's flagship project is the development of a bone graft product that can be used to treat various bone defects and fractures. The product is made from the patient's own fat cells, which are harvested, processed and cultured into bone tissue in the company's bioreactors. The bone tissue is then implanted into the patient's body, where it integrates with the existing bone and restores its function.

The company has received several awards and recognitions for its groundbreaking work in tissue engineering, such as the Frost & Sullivan Technology Innovation Award in 2016, the Israel Innovation Authority Grant in 2017, and the European Commission Horizon 2020 Grant in 2019. The company is also collaborating with leading academic and medical institutions in Israel and abroad, such as the Technion-Israel Institute of Technology, the Rambam Medical Center, and the Mayo Clinic.

Foundation: 2008

Headquarters: Haifa, Israel

Website: https://www.bonusbiogroup.com/